Related Experiment Video

Updated: May 23, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1

V Parikka1, K Näntö-Salonen, M Saarinen

  • 1Department of Pediatrics, Turku University Hospital, Kiinamyllynkatu 4-8, PO Box 52, 20521 Turku, Finland. vilpar@utu.fi

Diabetologia
|March 24, 2012
PubMed

Insights

Early detection of type 1 diabetes autoantibodies in children, especially within the first few years of life, strongly predicts disease progression. Higher autoantibody levels early on indicate a greater risk for developing type 1 diabetes before puberty.

Area of Science:

  • Pediatrics
  • Immunology
  • Endocrinology

Background:

  • Type 1 diabetes is an autoimmune disease characterized by the destruction of insulin-producing beta cells.
  • Autoantibodies are key biomarkers for predicting type 1 diabetes development.
  • Understanding the early kinetics of autoantibody appearance is crucial for timely intervention.

Purpose of the Study:

  • To investigate the timing of autoantibody appearance in relation to type 1 diabetes onset.
  • To determine the natural course of autoantibodies from birth to puberty.
  • To assess the predictive value of autoantibody concentrations for clinical progression.

Main Methods:

  • Longitudinal study of children at genetic risk for type 1 diabetes (Type 1 Diabetes Prediction and Prevention Project).
  • Regular analysis of autoantibodies against islet cells, insulin, GAD65, and islet antigen 2 from birth.
  • Monitoring of disease progression to clinical type 1 diabetes.

Main Results:

  • 18.4% of the cohort developed at least one autoantibody.
  • 184 autoantibody-positive children progressed to type 1 diabetes.
  • Seroconversion to autoantibodies occurred early (median 1.5 years), with most before age 3.
  • Higher autoantibody levels detected 3-6 months post-seroconversion predicted faster progression.

Conclusions:

  • Early onset of autoimmunity and rapid autoantibody titer increases are strong predictors of type 1 diabetes before puberty.
  • Early life events play a significant role in the development of type 1 diabetes.
  • Monitoring autoantibody dynamics in at-risk children can aid in early diagnosis and management.
Abstract

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...